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ABSTRACT
Introduction: Malaria caused by Plasmodium vivax species has shown signs of severity, recorded with increasing frequency in 
the medical literature. This study aimed to characterize the signs of severe malaria by Plasmodium vivax in the State of Maranhão, 
Brazil. Methods: A descriptive cohort study of patients assisted in the field and a historical and concurrent study of a series of 
cases among hospitalized patients were undertaken to identify the clinical and laboratory signs of severity. Results: A total of 153 
patients were included in the study, 13 of whom were hospitalized. Males made up the majority, numbering 103 (67.3%). The 
age of the patients ranged from 10 to 70 years, 92.2% were natives of the State of Maranhão, and 65% of the patients had had 
malaria before. The average time elapsed between symptom onset and diagnosis among outpatients was three days, while among 
hospitalized patients this average reached 15.5 days, a statistically significant difference (p=0.001). The parasitemia ranged from 
500 to 10,000 parasites/µl in 92.8% of cases. The clinical and laboratory manifestations of severity were vomiting and diarrhea, 
jaundice, drowsiness, mental confusion, seizures, loss of consciousness, agitation, bleeding, pale skin, coughing and dyspnea, 
thrombocytopenia, anemia, elevation of nitrogenous compounds, and elevated transaminases and bilirubin. Conclusions: The 
monitoring of malaria patients with Plasmodium vivax showed the possibility of aggravation, the intensity of which varied in 
different circumstances, especially the interval time between falling ill and diagnostic confirmation.
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Malaria is one of the most important diseases that affect 
humans, occurring in all tropical regions of the planet and in 
more than 109 countries. It is one of the major causes of death 
from infectious diseases, resulting in more than 300 million 
clinical cases and approximately one million deaths per year1. 
In Brazil, the incidence of malaria is concentrated in nine States 
of the Legal Amazon (Acre, Amazonas, Amapá, Rondônia, 
Roraima, Pará, Tocantins, Maranhão and Mato Grosso) and 
represents the main endemic disease in the State of Maranhão2.
A systematic reduction in the number of malaria cases has 
been observed in the State of Maranhão since 2000, when an 
intensified program to control malaria in the Amazon Region 
was implemented. In 2005 a total of 9,110 cases were diagnosed, 
of which 7,352 (80.7%) were by Plasmodium vivax3. In the 
following years this tendency continued, reaching a total of 
3,904 cases in 2010, with 3,000 (76.8%) by Plasmodium vivax4.
There is little information about the severity and possible 
related deaths from malaria by Plasmodium vivax, which 
usually manifests as a benign disease. Atypical manifestations 
and severe forms, however, have been registered and are 
characterized in particular by thrombocytopenia, jaundice, 
changes in level of consciousness, and severe anemia5-10. These 
events warn that more accurate observations of the disease 
should be made, especially in geographical areas where the 
species is predominant.
METHODS
Descriptive study of malaria cases with manifestations of  
severity assisted at ambulatory, from January to October 
2005, in Buriticupu, State of Maranhão, Brazil 
Located in the western region of the state, the municipality of 
Buriticupu integrates the administrative region of Açailândia. As 
an old area of agricultural settling, it occupies an area of 2,719km2 
consisting of equatorial forest, in transition with other ecosystems. The 
population is composed of 65,237 inhabitants11, and agriculture and 
wood extraction are the main economic activities. The municipality 
counts on the health service of the Universidade Federal do 
Maranhão, which also attends to patients from other municipalities.
In 2005 a total of 1,574 examinations were performed for 
malaria diagnosis. This resulted in 332 positive cases, of which 
292 were for Plasmodium vivax. Of this total, only 33 were 
autochthonous from the municipality. The others originated 
from other cities, states, and countries.
Historical and concurrent study from a series of cases with clinical 
and laboratorial manifestations of severity in patients hospitalized 




Raposo CCBS et al - Plasmodium vivax malaria: severity in the State of Maranhão, Brazil
RESULTS
in public and private general hospitals in São Luis, capital of 
State of Maranhão, Brazil, from January 1999 to December 2008.
Located in the western part of the Island of São Luis, the 
municipality of São Luis occupies an area of 831,700km2 and 
has a population of 966,989 inhabitants11. Patients with malaria 
were attended to by members of our team who routinely answer 
the calls from those care centers. Their clinical and laboratorial 
data were registered in specific form. 
Inclusion criteria to the two phases of study were patients 
older than two years old and with a definite diagnosis of mono-
infection by Plasmodium vivax malaria. Those with mixed 
infection, pregnant women, and patients with recognized chronic 
degenerative diseases and with clinical and/or laboratorial 
evidence of co-morbidities were excluded.
To investigate possible co-morbidities a detailed review of 
the medical records of all patients that had been attended to in 
Buriticupu was performed. Moreover, for inpatients, hepatitis 
serology was applied to those presenting jaundice. Other 
specific exams (dengue, kala-azar, enteric (typhoid) fever, and 
cytomegalovirus serology and blood culture) were performed 
according to the particular situation.
Parasitological diagnosis was done by the technique of thick 
blood film, stained using Giemsa and examined under a light 
microscope with immersion objective increases from 750 to 
1,000 times. To quantify the parasitemia a semi-quantitative 
classification of parasitemia was used, as proposed by Walker12.
Since there are no official criteria of severe malaria by 
Plasmodium vivax, the severity of the clinical presentation in this 
study was established from the classification of Alecrim6, as modified: 
I) Classical malaria: classic signs and symptoms of malaria such 
as fever (axillary temperature >37.5°C), chills, sweating, headache, 
vomiting, hepatomegaly and/or splenomegaly; II) Severe malaria: 
signs and symptoms of malaria, associated with one or more of 
the following laboratory and clinical complications: jaundice 
(total bilirubin >2mg/dL), anemia (hematocrit <30%), seizures, 
hypoglycemia (blood glucose <60mg/dL), thrombocytopenia 
(platelets <100,000/mm3), bleeding, coma, shock, hemoglobinuric 
fever, renal failure, splenic rupture, pulmonary disorders.
Statistical analysis
For the statistical analysis, the chi-square test was used or 
categorical variables and Fisher's exact test was used when 
the frequency was less than five elements. To compare the 
parasitemia level and severity manifestations the parasitemia 
classification proposed by Alecrim6, as modified, was 
considered. Test of hypothesis to evaluate equality of means 
of days between falling ill and diagnostic confirmation of 
patients in ambulatory care and those who were hospitalized 
was employed, using distribution t of Student. For evaluating 
statistical significance a  p value < 0.05 was considered. 
Ethical considerations
The research protocol, under registration 021/2005, was 
approved by the Ethics Committee in Human Research, Faculty 
of Medicine, University of Brasília. The protocol meets the 
requirements of the National Council Health.
Study of patients assisted in ambulatory care
We included 140 patients in the field study according to 
inclusion criteria, i.e. with  manifestation of severity. This 
represented 1.9% of the total number of Plasmodium vivax 
malaria in the State of Maranhão in 20053.
The majority of them were male, numbering 94 (67%). The 
patients' ages ranged from 10 to 70 years, with 102 (73.2%) over 
15 years. In the period of the study there was no register of 
patients less than 10 years old presenting criteria for severe 
malaria.
Autochthonous cases of Maranhão totaled 122 (87.1%), 
coming from the municipalities of Buriticupu, Bom Jardim, 
Bom Jesus das Selvas, Alto Alegre do Pindaré, and Santa Luzia. 
Imported cases from other states or countries accounted for 11 
(7.8%), coming from French Guyana, Suriname, and the State 
of Pará. The place of transmission could not be identified in 7 
(5%) patients. Forty-three (30.7%) patients had malaria for the 
first time, seventy-one (50.7%) for the second time, 20 (14.2%) 
for the third time, and six (4.3%) for more than the third time. 
The parasitemia of 130 (92.8%) patients did not exceed 10,000 
parasites/µl at the time of their diagnostic confirmation. Among 
the other 10 patients, only one had over 100,000 parasites/µl 
of blood. Considering the patients with primary infection, 38 
(88.3%) had less than 10,000 parasites/µl. Only 5 (11.6%) in 
this group of patients presented parasitemia higher than 10,000 
parasites/µl. Among those who had the disease for more than 
once, 91 (93.8%) had parasitemia less than 10,000/µl, while in five 
(5.1%) the parasitemia was higher than 10,000/µl. The statistical 
analysis showed no statistically significant difference between 
the variables of primary infection and parasitemia (p=0.176).
The maximum time elapsed between the onset of 
symptoms and the parasitological confirmation of diagnosis 
was 10 days, with an average of three days. For 60 (42.8%) 
patients, the elapsed time was 48 hours, and on this occasion 
51 (36.4%) patients already had parasitemia between 500 
and 10,000 parasites/µl. A comparison between the time 
shorter or longer than 48 hours and the levels of parasitemia 
presented by the patients (<10,000 and ≥10,000 parasites/mm3) 
showed no statistically significant association between these 
variables (p=0.636). The most frequent symptoms presented 
by patients were fever (100%), chills (99.3%), headache 
(99.3%), and sweating (86.4%). Among the manifestations 
of severity in this group of patients were gastrointestinal 
disorders, such as vomiting or diarrhea in 26 (18.5%), and 
jaundice in 3 (2.1%) patients. As for neurological disorders, 
the symptoms were agitation in 2 (1.4%), drowsiness in 2 
(1.4%), mental confusion in 1 (0.7%), loss of consciousness in 
2 (1.4%), and seizures in 2 (1.4%). Nine (6.4%) people had 
bleeding and 122 (87%) had cutaneous-mucosal pallor. With 
regard to respiratory disorders, 23 (16.4%) of the patients 
reported cough and 4 (2.9%) reported having had shortness 
of breath.
The association between the signs and symptoms of severity 
and the level of parasitemia was statistically significant in this 
sample, in the cases of mental confusion and agitation, while 
the variable bleeding showed a value of p very close to the 
considered significant value (Table 1).
Taking into account the average time elapsed from the onset 
of symptoms to the parasitological diagnosis (3 days), and 
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TABLE 1 - Association between the severity of signs and symptoms and parasitemia reported by patients with malaria by Plasmodium vivax, assisted in the ambulatory, State of Maranhão, 
Brazil, 2005-2008.
                                                                                              Parasitemia  
                                                                                             <10,000 (n=130)                                                  >10,000 (n=10)                                                     Total 
Signs and symptoms n % n % n P
Vomiting/diarrhea 26 20.0 0 0.0 26 0.117
Jaundice 3 2.3 0 0.0 3 0.627
Drowsiness 2 1.5 0 0.0 2 0.693
Mental confusion 0 0.0 1 10.0 1 <0.001
Convulsion 2 1.5 0 0.0 2 0.693
Loss of consciousness 2 1.5 0 0.0 2 0.693
Agitation 1 0.8 1 10.0 2 0.018
Bleeding 7 5.4 2 20.0 9 0.069
Pallor 114 87.7 8 80.0 122 0.484
Dyspnea 4 3.1 0 0.0 4 0.574
Cough 22 16.9 1 10.0 23 0.569
TABLE 2 - Association between the signs and symptoms of severity and the time elapsed between the onset of symptoms and diagnosis of patients with malaria by Plasmodium vivax, 
assisted in the field, State of Maranhão, Brazil, 2005-2008.
                                      Time until the diagnosis 
                                                                                                       < 3 days (n=99)                                              > 3 days (n=41)                                      Total 
Signs and symptoms n % n % n P
Vomiting/diarrhea 22 22.2 4 9.8 26 0.840
Jaundice 3 3.0 0 0.0 3 0.260
Drowsiness 2 2.0 0 0.0 2 0.359
Mental confusion 1 1.0 0 0.0 1 0.518
Convulsion 2 2.0 0 0.0 2 0.359
Loss of consciousness 1 1.0 1 2.4 2 0.517
Agitation 2 2.0 0 0.0 2 0.359
Bleeding 6 6.7 3 7.3 9 0.783
Pallor 89 89.8 33 80.4 122 0.130
Dyspnea 2 2.0 2 4.9 4 0.335
Cough 17 17.1 6 14.6 23 0.712
relating it to the signs and symptoms of severity presented by 
patients, it was not possible to establish a statistically significant 
association for any variable studied in this group of patients 
(Table 2).
Regarding the number of malarial affections with symptoms 
and signs of severity, it was observed that the symptoms that may 
denote complication were not significantly associated with the 
primary infection (Table 3). The variable of diarrhea showed a 
p value to closer to the considered statistically significant value.
Study of hospitalized patients
We studied 13 patients admitted to hospitals in São Luis 
from 1999 to 2008. Twelve patients came from the following 
municipalities of Maranhão: São Luis, São José de Ribamar, 
Itapecuru, Grajaú, São Bento, and Icatú. One patient got the 
infection in Pindaí, State of Amapá. Tables 4 and 5 present their 
clinical and laboratory data. The hepatitis serology performed 
on patients with jaundice was negative. Others exams, such as 
dengue, kala-azar, enteric (typhoid) fever, and cytomegalovirus 
serology and blood culture, were performed according to 
particular clinical conditions and were negative as well.
The age of these patients ranged from 10 to 58 years. All of 
them had primary infection and had time intervals between the 
disease and diagnostic confirmation from 6 to 41 days (mean 
15.5 days). When the hypothesis of equality of this average 
was tested against the average time between the diagnosis 
and confirmation of the disease seen in ambulatory patients 
(3 days), the difference was found to be significant (p=0.001). 




Among the identified signs of severity, jaundice was the 
most common, with one patient having developed cholecystitis 
without lithiasis. The neurological changes identified 
were dizziness, drowsiness, mental confusion, and loss of 
consciousness; the respiratory symptoms were dyspnea and 
pulmonary infiltrates seen on chest radiography.
The most frequent laboratorial complication was 
thrombocytopenia, with three (23%) patients having less than 
50,000 platelets/µl and two of these patients having conjunctival 
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TABLE 3 - Association between the signs and symptoms of severity and the number of malaria infections in patients with Plasmodium vivax malaria, assisted in the field, 
State of Maranhão, Brazil, 2005-2008.
                                                                                                             Number of malaria infections
                                                                                                     primary                               
                                                                                                                  infection (n=43)                    multi-infection
Signs and symptoms n %         (n=96) % Total p
Vomiting/diarrhea 4 9.3 22 22.9 26 0.059
Jaundice 1 2.3 2 2.1 3 0.779
Drowsiness 1 2.3 1 1.0 2 0.557
Mental confusion 1 2.3 0 0.0 1 0.134
Convulsion 1 2.3 1 1.0 2 0.557
Loss of consciousness 1 2.3 1 1.0 2 0.557
Agitation 0 0.0 2 2.1 2 0.340
Bleeding 3 7.0 6 6.3 9 0.703
Pallor 38 88.3 84 87.5 122 0.885
Dyspnea 2 4.7 2 2.1 4 0.225
Cough 10 23.2 12 12.5 22 0.082
TABLE 4 - Severe malaria caused by Plasmodium vivax in hospitalized patients, São Luis, State of Maranhão, Brazil, from 1999 to 2008.
 Old   Time to diagnosis Parasitemia 
Case (n) (years) Gender Origin (days) (parasites/µl) Signs of severity
1 26 M Autochthonous 10 501-10.00 Jaundice + thrombocytopenia + renal insufficiency
2 33 M Autochthonous 22 501-10.00 Jaundice+ thrombocytopenia+ anemia+ pulmonary disease
3 20 F Autochthonous 25 501-10.00 Jaundice + anemia + thrombocytopenia
4 38 M Autochthonous 12 501-10.00 Jaundice + thrombocytopenia
5 38 M Autochthonous 15 501-10.00 Jaundice + thrombocytopenia + pulmonary disease 
      + neurological disease + conjunctival hemorrhage
6 31 M Autochthonous 16 501-10.00 Jaundice + anemia
7 26 M Autochthonous 15 501-10.00 Jaundice + thrombocytopenia + anemia + neurological disease
8 58 M Imported 9 10.001 a 100.000 Thrombocytopenia + neurological disease
9 36 F Autochthonous 16 501-10.00 Neurological disease
10 29 M Autochthonous 7 501-10.00 Jaundice + thrombocytopenia + anemia + neurological disease
11 11 M Autochthonous 6 501-10.00 Jaundice + anemia + pulmonary disease + neurological disease 
      + hematúria + gastrointestinal bleeding
12 10 M Autochthonous 7 501-10.00 Jaundice + thrombocytopenia + neurological disease
13 21 F Autochthonous 41 501-10.00 Jaundice + thrombocytopenia
M: male; F: female.
hemorrhage, hematuria, and gastrointestinal bleeding. Other 
manifestations of severity were anemia with hemoglobin 
levels below 10g%, hiperbirrubinemia above 5mg/dL, elevated 
transaminases, and elevated nitrogenous compounds.
All patients in the study, with the exception of a hospitalized 
patient who received artemisinin because of a gastrointestinal 
bleeding, were treated with chloroquine associated with primaquine 
and presented a good clinical response and negative parasitemia in 




TABLE 5 - Laboratory tests results of patients hospitalized with severe malaria by Plasmodium vivax, São Luis, State of Maranhão, Brazil, from 1999 to 2008.
Case (n) Hg Ht Platelets AST ALT U Cr TB DB IB
1 11.8 35 45,000 64 74 150 6.3 26.5 13 13.5
2 9 26 49,800 41 38 20 0.4 10.6 5.3 5.3
3 9 26 72,000 58 18 19 1.2 2.9 1.7 1.2
4 10.6 30.8 18,000 84 67 64 1.15 19.23 11.28 7.95
5 14.4 42.5 71,000 59 64 - - 9.46 5.82 3.64
6 10.4 29.6 136,000 47.05 33.16 27 1 5.23 2.21 3.02
7 6.8 19.2 59,000 125 190 - 1.2 15.2 11 4.2
8 12.4 37.3 72,000 83 58 84 1 2.88 2.05 0.83
9 12.4 38.9 128,000 - - - - - - -
10 10.1 31.7 78,000 113 66 25 0.7 2.9 0.8 1.6
11 4.1 10.7 153,000 630 320 112 2.3 51.0 36.0 15.0
12 8 25.9 90,000 26 15 23 0.5 6.89 0.86 5.9
13 5.5 16 54,000 - - - - - - -
Hg: hemoglobin; Ht: hematocrit; AST: aspartate aminotransferase; ALT: alanine aminotransferase; U: urea; Cr: creatinine; TB: total bilirubin; DB: direct bilirubin; IB: indirect bilirubin. 
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The study presents some limitations, because it was 
composed of a retrospective part developed from data of 
patients attended in the field. At the beginning, the authors had 
difficulty defining the criteria of severe malaria by Plasmodium 
vivax, since there are no official criteria defined to this species. 
Thus, although the criteria of severity from Alecrim6 have not 
been published, they were adopted in this study considering 
the author first described such severe manifestations in the 
Brazilian Amazon. 
For the same reason it was not possible to apply polymerase 
chain reaction, which would allow the exclusion of possible 
mixed infection. However, the good clinical and parasitic 
response to treatment with chloroquine exhibited by patients 
reinforced the diagnoses of infection by Plasmodium vivax.
Plasmodium vivax malaria, predominant in the State of 
Maranhão, is commonly considered a benign condition13,14. 
However, clear signs of severity have been observed, and 
in some cases hospitalization is required due to medical 
complications, such as those that occurred in the 13 cases in 
this study.
Almost all the patients initially showed the classic clinical 
presentation of malaria, following the trend observed in endemic 
regions. However, even if this statement is true for these regions, 
atypical manifestations denoting severity have been observed in 
an increasing way6,8,15. Signs and symptoms, such as vomiting, 
diarrhea, jaundice, drowsiness, mental confusion, seizures, 
loss of consciousness, bleeding, and dyspnea, that registered 
in a significant percentage of patients confirm these findings.
Anemia, described as one of the major aggravations of 
malaria, is usually recorded as more severe in children and 
pregnant women with malaria by Plasmodium falciparum16,17. 
It was not possible to confirm this observation in this study, 
since there were no children less than 10 years old with severity 
manifestations while pregnant women were excluded.
However, as can be seen in the clinical and laboratory data of 
13 hospitalized patients, anemia can become a serious condition 
in Plasmodium vivax malaria, resulting in the need for blood 
transfusion, which occurred with four of our patients. The low 
frequency of neurological disorders among patients seen in the 
ambulatory contrasts with the high (58%) proportion among 
those hospitalized. Similarly, the occurrence of alterations in the 
respiratory, liver, and kidney functions are consistent with data 
reported by other authors in relation to malaria by Plasmodium 
vivax8,18,19. Noteworthy is the finding of jaundice in 2.1% of 
patients treated in ambulatory and in 58% of hospitalized 
patients, a sign that can lead to misdiagnosis, as observed in 
some patients who received an initial diagnosis of hepatitis. 
Serology and other laboratorial exams that proved negative 
excluded this diagnosis and other conditions. Moreover, with 
the specific treatment of malaria there was a normalization of 
serum bilirubin levels in the following days after the introduction 
of anti-malarial drugs.
Mild to moderate thrombocytopenia often occurs in 
malaria6,9, although only rarely manifests itself by spontaneous 
hemorrhages. In the present study the laboratory abnormality 
was documented more frequently among hospitalized patients. 
It was probably present in some patients treated in ambulatory. 
As verified by other authors6,9, the platelet count also normalized 
right after treatment. The lack of correct diagnosis and lack 
of understanding by health professionals that malaria by 
Plasmodium vivax can develop with such manifestations may 
lead to the performance of inappropriate exams and treatment.
Patients with primary infection, as expected, showed higher 
parasitemia, presumably with the absence of acquired immunity in 
previous contact with Plasmodium sp. It was observed, however, 
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that although these patients presented higher levels of parasitemia, 
this was not statistically significant and did not reflect the severity 
of the disease in these patients. Parasite density has been identified 
as a sign of bad prognosis8. In this study, there was no statistical 
relation between the level of parasitemia and the severity of 
clinical manifestations. In the analysis of the manifestations 
of severity, only mental confusion and agitation appear to be 
associated with parasitemia higher than 10,000 parasites/µl.
The delay in confirming the diagnosis was not reflected 
in high parasitemia. However, as can be seen in the study of 
hospitalized patients, the delay in establishing the diagnosis and 
beginning the treatment had negative repercussions and seems 
to have been decisive in the development and intensity of severe 
manifestations. A good clinical response, parasitologic clearance 
in the first two days of treatment, and no occurrence of deaths 
show that complications are reversible with proper treatment.
Data on parasitemia at day 28 after treatment were 
not available for all the patients and thus did not allow an 
evaluation of the possible development of in vivo chloroquine 
resistance, in line with other studies in the Brazilian Amazon20. 
Prospective studies need to be developed in the area for a better 
understanding of the issue.
The severity of Plasmodium vivax malaria may be associated 
with the circulating variant of the species in certain regions21. 
In the State of Maranhão knowledge of the genetic variations 
of Plasmodium vivax is incipient22, indicating the need for 
more research in this area for a clearer definition of this 
association. The National Plan for Malaria Control establishes 
early diagnosis and treatment as one of its main goals, toward 
reducing severity, mortality and disease transmission. It has 
been verified that although the State of Maranhão has shown a 
systematic reduction in the number of malaria cases in recent 
years2, it still has difficulties in diagnosing the total number of 
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